Femasys Inc.

FEMY

CIK 0001339005 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$813K
↑+39.9% +$232Kvs FY2024 (Q4)
Gross Profit
$510K
↑+31.1% +$121Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
50/100
  • Profitability
    0ROIC -340.0% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 4.53 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.14x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +39.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -500.9% · trend +393.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$525K
investment in PP&E
Stock buybacks (TTM)
$162K
share count reduction
Stock-based comp (TTM)
$790K
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$21M
everything owned
Total liabilities
$15M
everything owed
Stockholders' equity
$6M
shareholder claim

Recent performance · 23 quarters

Revenue↑+39.9% +$232K
$813K
Net Income↑+22.4% +$1M
$-4M
Free Cash Flow↓-30.9% -$33K
$-140K
Operating Margin↑+421.5pts
-500.9%

Drill down